Alexium International Group Limited · ASX:AJX
Alexium International — FY2023 Earnings Presentation
22 slides from Alexium International's earnings presentation, Aug 25, 2023
Slide 1: FY2023 Full Year Results
ALEXIUM INTERNATIONAL GROUP LIMITED FY2023 Full Year Results 25 August 2023 ABN 91 064 820 408 PRESENTED IN US DOLLARS
Slide 2: Disclaimer
Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an
Slide 3: Company Overview
COMPANY OVERVIEW
Slide 4: Company Overview
Company Overview “Alexium’s value to customers is technology enabling them to create a unique user experience that drives higher sales volumes at improved margins…” A performance materials company leveraging proprietary technical innovations to deliver thermal regulation, dehumidification and flam
Slide 5: Alexium's ESG Commitment
Alexium’s ESG Commitment By EOY FY2024, Alexium will SUSTAINABLE PRODUCT FOCUS: establish baselines, metrics and KPIs for ESG performance: Biocool® | Alexium’s proprietary biobased cooling Environment technology for textile & foam applications Biobased, sustainable raw materials Environment: was
Slide 6: Alexium Core Technologies
Alexium Core Technologies AlexiCool® PCM-based cooling products for textile & foam applications AlexiCool ® BioCool® BioCool® Proprietary bio-based cooling products for textile & foam applications Eclipsys® Eclipsys ® Perpetual cooling technology for textile & foam-based products DelCool™ Dehumidifi
Slide 7: FY23 Highlights
New Strategy: • Billy Blackburn, new CEO commenced September 2022. • Company restructure refocused efforts from product development to existing technologies commercialisation. • New strategy implemented focused on near-term results from bedding then diversify revenue and customer concentration throu
Slide 8: Market development – FY23 H2 Highlights
Market development – FY23 H2 Highlights Bedding Focus - Milestones: • Q4: First commercial revenue from production and sales of the new DelCool™ pillow liner to fill orders for a large US-based department store. Core Focus: • Q4: Successful BioCool® product qualification completed for two Grow & Div
Slide 9: FY23 & FY24 - Market Development Priorities
FY23 & FY24 - Market Development Priorities Grow and diversify through four key enablers: grow and diversify bedding market revenue, commercialise Eclipsys® for tactical gear, commercialise FR NyCo for military, and continued innovation. Core Focus Areas (70%) – Bedding Market Revenue: PCM, DelCool™
Slide 10: Bedding – Grow and Diversify
Bedding – Grow and Diversify WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY IN H1 FY24 ALEXIUM • AlexiCool®/BioCool® brands are established premium products, with sales to all US tier one mattress suppliers. • Continued revenue growth from PCM in textile • Revenue growth and customer diversification Adv
Slide 11: Eclipsys for Tactical Gear
Eclipsys® for Tactical Gear WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY IN H1 FY24 ALEXIUM • Improvements to Eclipsys® technology and • Successful results expected from field trials in • New revenue streams from new customers. manufacturing process led to new opportunities for late FY23/early FY24 sh
Slide 12: FR NyCo for Military Uniforms
FR NyCo for Military Uniforms & WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY IN H1 FY24 ALEXIUM • Alexium has created a flame-resistant nylon + • Deliver treated fabric for cut-and-sew of • New & large revenue streams. cotton fabric treatment utilising a combination of uniforms for the US Army to util
Slide 13: FY24 Forward Focus
The year ahead will be all about the execution of converting development opportunities into recurring revenue streams. With the business pipeline full of qualified growth projects, the company now shifts focus to strengthening its operations and supply chain in preparation for increased sales volume
Slide 14: FY2023 Overview
FY2023 OVERVIEW
Slide 15: Financial Snapshot
Financial Snapshot Revenue continues to recover for the second consecutive half year Full year revenue down 11.8% year over year, with H2 revenue increased by 30.6% versus same period prior year. Gross Profit continues to recover from a recent low in H2 FY22, up $318K. Gross margin at 39.1% is
Slide 16: Financial Spotlights
Financial Spotlights Profit and Loss Full year revenue down 11.8% year over year, with H2 revenue 30.6% higher than same period prior year. Operating expenses down 3.9% or $177K. Debt extinguishment charge of $577K related to the substantial modification of the existing note. Going Concern B
Slide 17: Financial Results
FINANCIAL RESULTS
Slide 18: Cash Flow Statement
Cash Flow Statement • Operating Activities outflows improved $0.5m with changes in: $(2.3)m – cash receipts on lower sales $2.7m - product purchases & manufacturing $0.1m – all other costs • Investment Activities outflows flat • CAPEX related to laptop replacement • Internal Development costs
Slide 19: Profit & Loss Statement
Profit & Loss Statement • While revenue has declined $1.0m year-on-year, the FY23 FY22 % business has experienced recent momentum with revenue (USD) (USD) Change Change growing for the second consecutive half year Sales Revenue 7,211 8,175 (964) (11.8%) Cost of Goods Sold (4,389) (4,845) 456 (9.4%)
Slide 20: Balance Sheet
Balance Sheet • Working Capital • Overall net working capital decreased by $0.5m. Trade receivables were higher on increased sales, offset by an inventory decrease due to utilisation, forecasting, and planning. • Non-Current Assets • Decrease of $0.2m with all categories in line with prior year afte
Slide 21: Appendix
APPENDIX
Slide 22: Non-GAAP Financial Measure Reconciliation
Non-GAAP Financial Measure Reconciliation Reconciliation of Operating EBITDA (non-GAAP financial measure) to statutory Net Profit/(Loss) FY23 FY22 The consolidated financial statements of the Group are general purpose financial statements which have been prepared in accordance with the (USD) (USD) A
Alexium International Group — FY2023 Earnings Presentation on 6ix